What does it actually feel like to live with early-onset Alzheimer’s disease, and what happens when treatment starts working?
About this event
In this inspiring session, the Youngtimers community will hear from a person was diagnosed with MCI due to Alzheimer’s and has been on anti-amyloid therapy with remarkable results. Mike Zuendel, founder of the Initiative to Change the “D-Word”, will shares what early symptoms felt like, how he knew the drug was working, and what life looks like when treatment may be keeping the disease at bay. For families living with familial Alzheimer’s disease, this is a hopeful glimpse into what this new era of treatment can mean.
About Mike Zuendel
Michael T. Zuendel is the Founder and Advocate in Chief of Initiative to Change the “D-Word”, a nonprofit organization focused on reducing stigma and promoting early detection of cognitive disorders. Diagnosed with Mild Cognitive Impairment due to Alzheimer’s disease in 2020, Mike draws on his personal journey and family caregiving experiences to advance patient-centered advocacy and more compassionate care.
He serves on multiple national and international advisory groups, including the Global Neuroscience Patient Council, the Alzheimer’s Patient Advisory Board of the Center for Study on Clinical Research Participation, and the Board of Directors of the Banner Alzheimer’s Institute Foundation.
He is a sought-after speaker in the United States and abroad, addressing topics of brain health, patient experience, and systemic change in Alzheimer’s care.
In addition to his advocacy work, Mike is Founder and CEO of Legacy Bridge Private Family Offices. A native of Des Moines, Iowa, he and his wife, Brooks, divide their time among Iowa, Colorado, and California. They have five adult children and enjoy skiing, paddle boarding, Baja off-road racing, and traveling together.
Who should attend?
This conversation is open to family members and researchers or professionals in the early Alzheimer's disease community.